Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glioblastoma multiforme (GBM) is a lethal brain tumour in adults and children. However, DNA copy number and gene expression signatures indicate differences between adult and paediatric cases. To explore the genetic events underlying this distinction, we sequenced the exomes of 48 paediatric GBM samples. Somatic mutations in the H3.3-ATRX-DAXX chromatin remodelling pathway were identified in 44% of tumours (21/48). Recurrent mutations in H3F3A, which encodes the replication-independent histone 3 variant H3.3, were observed in 31% of tumours, and led to amino acid substitutions at two critical positions within the histone tail (K27M, G34R/G34V) involved in key regulatory post-translational modifications. Mutations in ATRX (α-thalassaemia/mental retardation syndrome X-linked) and DAXX (death-domain associated protein), encoding two subunits of a chromatin remodelling complex required for H3.3 incorporation at pericentric heterochromatin and telomeres, were identified in 31% of samples overall, and in 100% of tumours harbouring a G34R or G34V H3.3 mutation. Somatic TP53 mutations were identified in 54% of all cases, and in 86% of samples with H3F3A and/or ATRX mutations. Screening of a large cohort of gliomas of various grades and histologies (n = 784) showed H3F3A mutations to be specific to GBM and highly prevalent in children and young adults. Furthermore, the presence of H3F3A/ATRX-DAXX/TP53 mutations was strongly associated with alternative lengthening of telomeres and specific gene expression profiles. This is, to our knowledge, the first report to highlight recurrent mutations in a regulatory histone in humans, and our data suggest that defects of the chromatin architecture underlie paediatric and young adult GBM pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Histone H3 lysine27-to-methionine (H3K27M) gain-of-function mutations occur in highly aggressive pediatric gliomas.”
From Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling (2014) · cites this paper as [3]
In the citing paper
“Indeed, the K27M mutation has been observed to occur in genes encoding all forms of histone H3 (H3.1, H3.2, and H3.3) in human glioma (1,10,24).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [1]
In the citing paper
“ALT is associated with mutations in the chromatin remodeller α-thalassaemia/mental retardation syndrome X-linked (AT R X ) both in vitro and in several human cancers, including glioblastomas162–165.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [163]
In the citing paper
“The H3.3G34R/V mutated tumours are found almost exclusively in the cerebral hemispheres 101,102 , whereas H3.1K27M tumours are restricted to an area of the brainstem called the pons and H3.3K27M tumours can also be found along the midline of the brain 106 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [106]
In the citing paper
“A heterozygous point mutation of histone H3 occurs in more than 80% of these tumors, and results in a lysine-to-methionine substitution (H3K27M)2,3.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [2]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Cited by
Items 601–700 of 1,001
Sitbon, D., Boyarchuk, E., Dingli, F., Loew, D., & Almouzni, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15084-4 · Cited by 64
Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer
Pajovic, S., Siddaway, R., Bridge, T., Sheth, J., Rakopoulos, P., Kim, B., Ryall, S. T., Agnihotri, S., Phillips, L., Yu, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19972-7 · Cited by 71
Telomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 75
“3 are frequently associated with ALT (Heaphy et al. 2011, Schwartzentruber et al. 2012).”
BackgroundEts Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma
Breunig, J. J., Levy, R., Antonuk, C. D., Molina, J., Dutra‐Clarke, M., Park, H., Akhtar, A. A., Kim, G. B., Town, T., Hu, X., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.012 · Cited by 73
CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy
Yao, S., He, Z., & Chen, C. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.067 · Cited by 72
“14,15 72 This evidence strongly supports the notion that epigenetic mechanisms may act as driving forces during carcinogenesis and support cancer cell survival and proliferation.”
Telomere regulation in pluripotent stem cells
Huang, Y. Y., Liang, P., Liu, D., Huang, J., & Songyang, Z. (2014) · Protein & Cell · doi:10.1007/s13238-014-0028-1 · Cited by 77
The histone variant H2A.Bbd is enriched at sites of DNA synthesis
Sansoni, V., Casas-Delucchi, C. S., Rajan, M., Schmidt, A., Bönisch, C., Thomae, A. W., Staege, M. S., Hake, S. B., Cardoso, M. C., & Imhof, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku303 · Cited by 78
“3 variant for example has been found to carry a driving mutation in paediatric glioblastoma (13,14).”
BackgroundEpigenetic mechanisms underlying nervous system diseases
Qureshi, I., & Mehler, M. F. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00005-1 · Cited by 78
“3 in a high proportion of pediatric gliomas and histone lysine methylation-related factors in medulloblastomas (Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 2012; Chan et al., 2013).”
BackgroundBPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
Green, A. L., DeSisto, J. A., Flannery, P. C., Lemma, R., Knox, A. J., Lemieux, M. E., Sanford, B. L., O’Rourke, R., Ramkissoon, S. H., Jones, K. L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1125-7 · Cited by 72
Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas
Mosaab, A., El‐Ayadi, M., Khorshed, E. N., Amer, N., Refaat, A., Beltagy, M. A. E., Hassan, Z., Soror, S. H. A., Zaghloul, M. S., & El‐Naggar, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65272-x · Cited by 73
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Brat, D. J., Aldape, K., Bridge, J. A., Canoll, P., Colman, H., Hameed, M. R., Harris, B. T., Hattab, E. M., Huse, J. T., Jenkins, R. B., et al. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0295-cp · Cited by 83
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
Gianno, F., Giovannoni, I., Cafferata, B., Diomedi‐Camassei, F., Minasi, S., Barresi, S., Buttarelli, F. R., Alesi, V., Cardoni, A., Antonelli, M., et al. (2022) · Pathologica · doi:10.32074/1591-951x-830 · Cited by 74
Exomic Sequencing of Four Rare Central Nervous System Tumor Types
Bettegowda, C., Agrawal, N., Jiao, Y., Wang, Y., Wood, L. D., Rodríguez, F. J., Hruban, R. H., Gallia, G. L., Binder, Z. A., Riggins, C. J., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.964 · Cited by 73
“3 gene was detected in only 1 of 17 samples via next generation sequencing[10, 11].”
InfluentialRodríguez, F. J., Brosnan‐Cashman, J. A., Allen, S. J., Vizcaíno, M. A., Giannini, C., Camelo-Piragua, S. I., Webb, M., Matsushita, M., Wadhwani, N. R., Tabbarah, A. Z., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12646 · Cited by 69
“ATRX mutations and ALT are also associated with specific molecular subgroups of brain tumors, particularly a subset of pediatric glioblastoma (41) and IDH mutant diffuse astrocytomas (3,28).”
BackgroundTargeting Chromatin Remodeling for Cancer Therapy
Kaur, J., Daoud, A., & Eblen, S. T. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190215112915 · Cited by 73
Zhang, T., Zhang, Z., Shengzhao, G., Li, X., Liu, H., & Zhao, Y. B. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007925 · Cited by 75
Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines
Mehta, N. K., Pradhan, R. V., Soleimany, A. P., Moynihan, K. D., Rothschilds, A. M., Momin, N., Rakhra, K., Mata-Fink, J., Bhatia, S. N., Wittrup, K. D., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0563-4 · Cited by 66
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Panditharatna, E., Marques, J. G., Wang, T., Trissal, M. C., Liu, I., Jiang, L., Beck, A., Groves, A. P., Dharia, N. V., Li, D., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1491 · Cited by 73
“6-μm C18 spherical silica beads into a fused silica capillary (100-μm inner diameter × ∼30 cm length) with a flame-drawn tip (2).”
BackgroundPachocki, C. J., & Hol, E. M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02630-8 · Cited by 71
“Particularly histone H3 mutations, which are very infrequently found in adult high-grade gliomas, are highly present in DMG patients [57, 58].”
BackgroundMurnyák, B., Kouhsari, M. C., Hershkovitch, R., Kálmán, B., Marko‐Varga, G., Klekner, Á., & Hortobágyi, T. (2017) · Oncotarget · doi:10.18632/oncotarget.18013 · Cited by 72
“Cases for the analysis were selected according to the following criteria: I) only patients older than 18 years with available clinical data were included, considering that paediatric GBM represents a distinct molecular and genetic background (see reviews [42, 43]); II) oligodendrogliomas and mixed gliomas were omitted…”
MethodBailey, C. P., Figueroa, M., Gangadharan, A., Yang, Y., Romero, M. M., Kennis, B. A., Yadavilli, S., Henry, V. K., Collier, T. L., Monje, M., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa058 · Cited by 70
Solid tumours hijack the histone variant network
Ghiraldini, F. G., Filipescu, D., & Bernstein, E. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00330-0 · Cited by 69
He, C., Xu, K., Zhu, X., Dunphy, P. S., Gudenas, B. L., Lin, W., Twarog, N. R., Hover, L. D., Kwon, C.-H., Kasper, L. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24168-8 · Cited by 70
The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021
Perez, A., & Huse, J. T. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01153-8 · Cited by 76
Spinal cord tumours: advances in genetics and their implications for treatment
Zadnik, P. L., Gokaslan, Z. L., Burger, P. C., & Bettegowda, C. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.48 · Cited by 68
Molecular mechanisms and therapeutic targets in pediatric brain tumors
Liu, K.-W., Pajtler, K. W., Worst, B. C., Pfister, S. M., & Wechsler‐Reya, R. J. (2017) · Science Signaling · doi:10.1126/scisignal.aaf7593 · Cited by 71
Self-citationBrosnan‐Cashman, J. A., Yuan, M., Graham, M. K., Rizzo, A. J., Myers, K. M., Davis, C., Zhang, R., Esopi, D., Raabe, E. H., Eberhart, C. G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204159 · Cited by 70
Spinelli, C., Adnani, L., Choi, D., & Rak, J. W. (2018) · Non-Coding RNA · doi:10.3390/ncrna5010001 · Cited by 69
“It is of interest to note that YB1 is among the most upregulated genes in pediatric high-grade glioma, along with another vesicle transport-associated protein SNX3 [108], which may suggest that EV-mediated trafficking of regulatory RNAs could play a role in the pathogenesis of this disease, otherwise already linked to…”
BackgroundAssembly of telomeric chromatin to create ALTernative endings
O’Sullivan, R. J., & Almouzni, G. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.007 · Cited by 75
Bae, W. K., Yoo, K. H., Lee, J. S., Kim, Y., Chung, I., Park, M. H., Yoon, J. H., Furth, P. A., & Hennighausen, L. G. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22188 · Cited by 69
Hu, J. L., Western, S., & Kesari, S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00180 · Cited by 68
“H3F3A mutations at G34 are typically found in the cerebral hemispheres and occur in adolescence and in young adults, in contrast with H3F3A mutations at K27, which are most common in brainstem gliomas of young children, but may also occur in adults as shown by this study (9, 29).”
BackgroundLinking Telomere Regulation to Stem Cell Pluripotency
Liu, L. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.10.007 · Cited by 75
Ryall, S. T., Tabori, U. Y., & Hawkins, C. E. (2017) · Brain Tumor Pathology · doi:10.1007/s10014-017-0282-z · Cited by 73
Self-citationStandardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
Li, D. D., Bonner, E. R., Wierzbicki, K., Panditharatna, E., Huang, T., Lulla, R. R., Mueller, S., Koschmann, C. J., Nazarian, J., & Saratsis, A. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-84513-1 · Cited by 72
The current landscape of immunotherapy for pediatric brain tumors
Hwang, E. I., Sayour, E. J., Flores, C. T., Grant, G. A., Wechsler‐Reya, R. J., Hoang-Minh, L., Kieran, M. W., Salcido, J., Prins, R. M., Figg, J., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00319-0 · Cited by 73
Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
Khayari, A. E., Bouchmaa, N., Taïb, B., Wei, Z., Zeng, A., & Fatimy, R. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901951 · Cited by 68
“Notably, mutations in IDH 1/2, EGFR, H3F3A, MLL2-4, HDAC2, HDAC9, KDM4D, KDM5A/B/ C, and KDM6A/B have been observed to promote DNA and histone methylation and modify chromatin state, thereby inducing aberrant modifications in the epigenetic pattern and consequently affecting the gene expression profile in GBM cells (1…”
BackgroundWells, E. M., & Packer, R. J. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464176.96311.d1 · Cited by 82
“Substantial differences have been found in the molecular features of pediatric and adult high-grade gliomas, as well as variations with age and anatomical site.(46) A study of 127 high-grade gliomas, including DIPGs and nonY brainstem high-grade gliomas, identified frequent somatic mutations in histone H3 genes (varyi…”
BackgroundHistone modifications and a choice of variant: a language that helps the genome express itself
Gurard‐Levin, Z. A., & Almouzni, G. (2014) · F1000Prime Reports · doi:10.12703/p6-76 · Cited by 70
“Notably, it is important to consider instances where histones do not have the capacity to bear the same modifications either due to mutations [88-91] or the presence of variants, such as the centromeric H3 variant”
BackgroundResultCai, J., Chen, J., Zhang, W., Yang, P., Zhang, C., Li, M., Yao, K., Wang, H., Li, Q., Jiang, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3906 · Cited by 71
“Recent reports described that ATRX mutation or loss occurred at high percentages in multiple tumor types, including low grade astrocytoma and secondary glioblastoma, suggestive of a potential “driver” role in cancer [9–11].”
BackgroundSelf-citationEpigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma
Furukawa, Y., & Kikuchi, J. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2048-5 · Cited by 69
“Furthermore, somatic mutations in H3K27 have been observed in aggressive gliomas [100, 101].”
BackgroundCombination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma
Zhang, Y., Dong, W., Zhu, J., Wang, L., Wu, X., & Shan, H. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0184-0 · Cited by 68
“H3K27M is sufficient to generate tumors As reported, H3K27M‐mutant expression in DIPGs is associated with up‐regulation of PDGF signaling [4, 5], so we expressed Flag‐tagged K27M H3.”
Zápotocký, M., Ramaswamy, V., Lassaletta, Á., & Bouffet, É. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26861 · Cited by 71
Live-cell single-molecule dynamics of PcG proteins imposed by the DIPG H3.3K27M mutation
Tatavosian, R., Duc, H. N., Huynh, T. N., Fang, D., Schmitt, B., Shi, X., Deng, Y., Phiel, C. J., Yao, T., Zhang, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04455-7 · Cited by 64
Liu, I., Cruzeiro, G. A. V., Bjerke, L. M., Rogers, R. F., Grabovska, Y., Beck, A., Mackay, A. G., Barron, T., Hack, O. A., Quezada, M. A., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.006 · Cited by 71
Green, A. L., & Kieran, M. W. (2015) · Current Oncology Reports · doi:10.1007/s11912-014-0436-7 · Cited by 68
Neuroendocrine tumours: cracking the epigenetic code
Karpathakis, A., Dibra, H. K., & Thirlwell, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0338 · Cited by 71
“(1998) HPM 52% gastrinomas Serrano et al. (2000) HPM 11.8% insulinomas Bartsch et al. (2000) HPM in QGP1 but not BON Lubomierski et al.”
BackgroundMethodInfluentialChan, K. M., Han, J., Fang, D., Gan, H., & Zhang, Z. (2013) · Cell Cycle · doi:10.4161/cc.25625 · Cited by 68
“1).(1,2) The two histone H3 mutations are mutually exclusive and give rise to tumors in different brain compartments.”
BackgroundPlessier, A., Dret, L. L., Varlet, P., Beccaria, K., Lacombe, J., Mériaux, S., Geffroy, F., Fiette, L., Flamant, P., Chrétien, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15002 · Cited by 65
“The recent identification in midline pediatric glioma and in particular in DIPG, of a specific point mutation in H3F3A, HIST1H3B/C, HIST2H3A/C histone genes – leading to the replacement of a lysine by a methionine at position 27, has set the basis for a molecular definition of these gliomas [6–8].”
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity
Lovejoy, C. A., Takai, K., Huh, M. S., Picketts, D. J., & de Lange, T. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000594 · Cited by 68
-Thalassemia, Mental Retardation, and Myelodysplastic SyndromePreprint
Gibbons, R. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011759 · Cited by 64
“3 that ATRX/Daxx deposit into chromatin has reignited the issue (Heaphy et al. 2011; Jiao et al. 2011; Schwartzentruber et al. 2012).”
BackgroundNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes
An, Ö., Pendino, V., D’Antonio, M., Ratti, E., Gentilini, M., & Ciccarelli, F. D. (2014) · Database · doi:10.1093/database/bau015 · Cited by 68
Childhood Malignant Brain Tumors: Balancing the Bench and Bedside
Thorbinson, C., & Kilday, J. (2021) · Cancers · doi:10.3390/cancers13236099 · Cited by 68
“At least nine subgroups are thought to exist, with biological and clinical features highlighted in accordance with [84,90,91].”
BackgroundThe role of histone H3K36me3 writers, readers and erasers in maintaining genome stability
Sharda, A., & Humphrey, T. C. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103407 · Cited by 68
Vallero, S. G., Bertero, L., Morana, G., Sciortino, P., Bertin, D., Mussano, A., Ricci, F., Peretta, P., & Fagioli, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1082062 · Cited by 69
“2 variant has also been documented (22, 23).”
BackgroundIs Glioblastoma an Epigenetic Malignancy?
Maleszewska, M., & Kaminska, B. (2013) · Cancers · doi:10.3390/cancers5031120 · Cited by 57
A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells
Misuraca, K. L., Hu, G., Barton, K. L., Chung, A., & Becher, O. J. (2016) · Neoplasia · doi:10.1016/j.neo.2015.12.002 · Cited by 66
“3, with the latter being more common and associating with a worse prognosis [3] [4] [5] [6] [7].”
Molecular pathology of paediatric central nervous system tumours
Chiang, J., & Ellison, D. W. (2016) · The Journal of Pathology · doi:10.1002/path.4813 · Cited by 66
“H3F3A G34R/V mutations are most commonly found in parietal, occipital, and temporal lobe HGGs from adolescents and young adults [66,70].”
BackgroundInfluentialBMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
Kumar, S. S., Sengupta, S., Lee, K., Hura, N., Fuller, C. E., DeWire, M. D., Stevenson, C. B., Fouladi, M., & Drissi, R. (2017) · Oncotarget · doi:10.18632/oncotarget.18002 · Cited by 67
Cell Fate and Developmental Regulation Dynamics by Polycomb Proteins and 3D Genome Architecture
Loubiere, V., Martinez, A., & Cavalli, G. (2019) · BioEssays · doi:10.1002/bies.201800222 · Cited by 63
Brumbaugh, J., Kim, I. S., Ji, F., Huebner, A. J., Stefano, B. D., Schwarz, B. A., Charlton, J., Coffey, A., Choi, J., Walsh, R. M., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0403-5 · Cited by 64
Histone Variants: Guardians of Genome Integrity
Ferrand, J., Rondinelli, B., & Polo, S. E. (2020) · Cells · doi:10.3390/cells9112424 · Cited by 65
“3 mutations were shown to co-occur with other genetic alterations, such as amplification of platelet-derived growth factor receptor α (PDGFRα) or mutations in the DAXX-ATRX chaperone complex [116,156,157].”
BackgroundLawlor, R. T., Veronese, N., Pea, A., Nottegar, A., Smith, L., Pilati, C., Demurtas, J., Fassan, M., Cheng, L., & Luchini, C. (2019) · BMC Cancer · doi:10.1186/s12885-019-5424-8 · Cited by 62
Balancing DNA repair to prevent ageing and cancer
Stead, E. R., & Bjedov, I. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112679 · Cited by 73
McCrea, H. J., Ivanidze, J., O’Connor, A., Hersh, E. H., Boockvar, J. A., Gobin, Y. P., Knopman, J., & Greenfield, J. P. (2021) · Journal of Neurosurgery Pediatrics · doi:10.3171/2021.3.peds20738 · Cited by 65
Histone H1 alterations in cancer
Scaffidi, P. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.09.008 · Cited by 66
Histone variant H3F3A promotes lung cancer cell migration through intronic regulation
Park, S., Choi, E.-Y., Bae, M., Kim, S., Park, J. B., Yoo, H., Choi, J. K., Kim, Y., Lee, S., & Kim, I.-H. (2016) · Nature Communications · doi:10.1038/ncomms12914 · Cited by 65
Giant cell tumor of soft tissue is genetically distinct from its bone counterpart
Lee, J., Liang, C., & Fletcher, C. D. �. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.236 · Cited by 65
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
Williams, M. J., Singleton, W., Lowis, S. P., Malik, K. T. A., & Kurian, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00045 · Cited by 65
“Mutations in H3F3A involve two critical single-point mutations in the histone tail at lysine (K) 27 (K27M) and glycine (G) 34 (G34R/V), both of which are involved with key regulatory posttranscriptional modifications (13).”
BackgroundInfluentialHigh-grade glioma in very young children: a rare and particular patient population
El‐Ayadi, M., Ansari, M., Sturm, D., Gielen, G. H., Warmuth‐Metz, M., Kramm, C. M., & von Bueren, A. O. (2017) · Oncotarget · doi:10.18632/oncotarget.18478 · Cited by 63
“1 were recently recognized in pediatric HGG as the first reported histone mutations associated with human malignancies [35, 36].”
BackgroundInfluentialSelf-citationConstructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
Smith, R. C., & Tabar, V. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.012 · Cited by 63
Target identification reveals lanosterol synthase as a vulnerability in glioma
Phillips, R. E., Yang, Y., Smith, R. C., Thompson, B. M., Yamasaki, T., Soto‐Feliciano, Y. M., Funato, K., Liang, Y., García‐Bermúdez, J., Wang, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820989116 · Cited by 73
“Neither driver mutations in menin, nor MLL fusions occur in adult glioma or DIPG (2, 3, 14), and the role of wild-type menin in driving oncogenic gene transcription in different glioma subtypes has not been systematically evaluated.”
BackgroundHistone H3 Mutations in Cancer
Wan, Y. C. E., Liu, J., & Chan, K. M. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0141-6 · Cited by 64
“3G34 were found in glioblastoma (G34R/V) [4, 6], giant cell tumor of the bone (G34W/L), and osteosarcoma (G34R/V) [36].”
BackgroundRegulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity
Das, P., & Taube, J. H. (2020) · Cancers · doi:10.3390/cancers12102792 · Cited by 65
The Role of Neurodevelopmental Pathways in Brain Tumors
Curry, R. N., & Glasgow, S. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.659055 · Cited by 64
“The consequences of these histone mutations result in global dysregulation, particularly overexpression of entire chromosomal regions including the expression of essential developmental regulators of cell proliferation, migration and differentiation (Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 2012;…”
BackgroundG-quadruplexes mark alternative lengthening of telomeres
Yang, S. Y. C., Chang, E. Y., Lim, J., Kwan, H., Monchaud, D., Yip, S. S. F., Stirling, P. C., & Wong, J. M. Y. (2021) · NAR Cancer · doi:10.1093/narcan/zcab031 · Cited by 62
“Some G4 and R-loop foci from our analyses appeared to resemble the large telomere foci widely seen in ALT+ cells in multiple previous studies (3,4,32).”
Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas
Harpaz, N., Mittelman, T., Beresh, O., Griess, O., Furth, N., Salame, T., Oren, R., Fellus‐Alyagor, L., Harmelin, A., Alexandrescu, S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.023 · Cited by 65
Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation
Tibben, B. M., & Rothbart, S. B. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168394 · Cited by 64
Subashi, E., Cordero, F. J., Halvorson, K. G., Qi, Y. P., Nouls, J. C., Becher, O. J., & Johnson, G. A. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1969-9 · Cited by 66
“These histone mutants have been shown to globally decrease trimethylation of Lys27 on most H3s, working as potent inhibitors of EZH2, leading to global epigenetic and transcriptomal changes [6, 12, 13].”
Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma
Hochart, A., Escande, F., Rocourt, N., Grill, J., Koubi-Pick, V., Beaujot, J., Meignan, S., Vinchon, M., Maurage, C., & Leblond, P. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.184 · Cited by 63
“3 insertion is affected, and gene expression in the tumor cells is profoundly modified.(3,4,11) The H3F3A K27M mutation is characteristic of midline HGG in children.”
Venneti, S., Felicella, M. M., Coyne, T., Phillips, J. J., Gorovets, D., Huse, J. T., Kofler, J., Lu, C., Tihan, T., Sullivan, L. M., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182898113 · Cited by 59
Scelfo, A., Piunti, A., & Pasini, D. (2015) · The FEBS Journal · doi:10.1111/febs.13112 · Cited by 61
Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands
Min, J., Wright, W. E., & Shay, J. W. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1295 · Cited by 75
Azad, T. D., Jin, M. C., Bernhardt, L. J., & Bettegowda, C. (2020) · Neurosurgical FOCUS · doi:10.3171/2019.9.focus19699 · Cited by 69
Koschmann, C. J., Lowenstein, P. R., & Castro, M. G. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1167158 · Cited by 61
“tively referred to as alternative lengthening of telomeres (ALT).(3) However, no efforts have been made to target ATRX”
BackgroundWorkman, P., Al‐Lazikani, B., & Clarke, P. A. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.004 · Cited by 65
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
Ruscio, V. D., Baldo, G. D., Fabozzi, F., Vinci, M., Cacchione, A., de Billy, E., Megaro, G., Carai, A., & Mastronuzzi, A. (2022) · Diagnostics · doi:10.3390/diagnostics12092064 · Cited by 67
“The intrinsic localization of this tumor into midline structures contributes to the poor outcome of those patients; the widespread infiltrative nature as well as the critical anatomical location precludes surgical resection, while the presence of an intact blood–brain barrier (BBB) [4] hinders drug penetration into th…”
BackgroundInfluentialPre-Clinical Models of Diffuse Intrinsic Pontine Glioma
Misuraca, K. L., Cordero, F. J., & Becher, O. J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00172 · Cited by 66
“1 (5, 8, 17) and ACVR1 (18–21) further refined the characterization of DIPG subgroups.”
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 63
“3 mutations in pediatric glioblastomas (Schwartzentruber et al. 2012; Wu et al. 2012; Khuong-Quang et al. 2012; Sturm et al. 2012) or linking H3.”
BackgroundABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B–Driven Brainstem Glioma Model
Mittapalli, R. K., Chung, A. H., Parrish, K. E., Crabtree, D., Halvorson, K. G., Hu, G., Elmquist, W. F., & Becher, O. J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0093 · Cited by 65
“3 and activating mutations in ACVR1 (5–10).”
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer
Koschmann, C. J., Núñez, F. J., Mendez, F., Brosnan‐Cashman, J. A., Meeker, A. K., Lowenstein, P. R., & Castro, M. G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2301 · Cited by 64
“3) result in critical downstream epigenetic alterations, contributing to tumor growth in pediatric glioblastoma, chondroblastoma, and undifferentiated sarcoma (12, 13).”
Combined burden and functional impact tests for cancer driver discovery using DriverPower
Shuai, S., PCAWG Drivers and Functional Interpretation Working Group, Abascal, F., Amin, S. B., Bader, G. D., Bandopadhayay, P., Barenboim, J., Beroukhim, R., Bertl, J., Boroevich, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13929-1 · Cited by 59
Self-citationNejo, T., Yamamichi, A., Almeida, N. D., Goretsky, Y. E., & Okada, H. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101385 · Cited by 64
Prediction of Molecular Mutations in Diffuse Low-Grade Gliomas using MR Imaging Features
Shboul, Z. A., Chen, J. Y., & Iftekharuddin, K. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60550-0 · Cited by 67
Williams, E. A., Brastianos, P. K., Wakimoto, H., Zolal, A., Filbin, M. G., Cahill, D. P., Santagata, S., & Juratli, T. A. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02609-6 · Cited by 61
Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
Rizzo, D., Ruggiero, A., Martini, M., Rizzo, V., Maurizi, P., & Riccardi, R. (2015) · BioMed Research International · doi:10.1155/2015/215135 · Cited by 65
Simeonova, I., & Huillard, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1675-3 · Cited by 64
“Molecular alterations in high-grade pediatric astrocytomas (anaplastic astrocytoma and GBM) are starting to be described [37, 38], but in the case of lowgrade tumors, the cellular origins and molecular alterations are less well understood.”
BackgroundPRC2 during vertebrate organogenesis: A complex in transition
Aldiri, I., & Vetter, M. L. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.04.030 · Cited by 55
Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma
Agnihotri, S., Aldape, K., & Zadeh, G. M. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.9.focus14505 · Cited by 63
Viral Reprogramming of the Daxx Histone H3.3 Chaperone during Early Epstein-Barr Virus Infection
Tsai, K., Chan, L., Gibeault, R., Conn, K. L., Dheekollu, J., Domsic, J. F., Marmorstein, R., Schang, L. M., & Lieberman, P. M. (2014) · Journal of Virology · doi:10.1128/jvi.01895-14 · Cited by 62
Telomere dysfunction and chromothripsis
Ernst, A., Jones, D., Maaß, K. K., Rode, A., Deeg, K. I., Jebaraj, B. M. C., Korshunov, A., Hovestadt, V., Tainsky, M. A., Pajtler, K. W., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30033 · Cited by 63
“Telomere-specific FISH was performed using a FITC-labeled peptide nucleic acid telomere probe (Dako, Glostrup, Denmark) as previously described.(26) The ALT phenotype is characterized by a variable number of large, ultra-bright telomere DNA aggregates.”
MethodSelf-citation
Metadata
- Authors
- Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., Hovestadt, V., Albrecht, S., Kool, M., Nantel, A., Konermann, C., Lindroth, A., Jäger, N., Rausch, T., Ryzhova, M., Korbel, J. O., Hielscher, T., Hauser, P., Garami, M., Klekner, A., Bognar, L., Ebinger, M., Schuhmann, M. U., Scheurlen, W., Pekrun, A., Frühwald, M. C., Roggendorf, W., Kramm, C., Dürken, M., Atkinson, J., Lepage, P., Montpetit, A., Zakrzewska, M., Zakrzewski, K., Liberski, P. P., Dong, Z., Siegel, P., Kulozik, A. E., Zapatka, M., Guha, A., Malkin, D., Felsberg, J., Reifenberger, G., von Deimling, A., Ichimura, K., Collins, V. P., Witt, H., Milde, T., Witt, O., Zhang, C., Castelo-Branco, P., Lichter, P., Faury, D., Tabori, U., Plass, C., Majewski, J., Pfister, S. M., & Jabado, N.
- Affiliations
- McGill University and Génome Québec Innovation Centre (CA)
- German Cancer Research Center (DE)
- McGill University (CA)
- Montreal Children's Hospital (CA)
- European Molecular Biology Laboratory (DE)
- Burdenko Neurosurgery Institute (RU)
- University Children's Hospital Tübingen (DE)
- Universitätsklinikum Tübingen (DE)
- Cnopf´sche Kinderklinik (DE)
- Prof. Hess Kinderklinik (DE)
- University Hospital Augsburg (DE)
- University of Würzburg (DE)
- University Hospital in Halle (DE)
- Medical University of Lodz (PL)
- University Hospital Heidelberg (DE)
- University of Toronto (CA)
- Heinrich Heine University Düsseldorf (DE)
- University of Cambridge (GB)
- McGill University Health Centre (CA)
- Corresponding author
- Majewski, Jacek
- Pfister, Stefan M.
- Jabado, Nada
- ORCID
- Schwartzentruber, Jeremy
- Korshunov, Andrey
- Jones, David T. W.
- Pfaff, Elke
- Sturm, Dominik
- Hovestadt, Volker
- Albrecht, Steffen
- Kool, Marcel
- Lindroth, Anders
- Jäger, Natalie
- Rausch, Tobias
- Ryzhova, Marina
- Korbel, Jan O.
- Hielscher, Thomas
- Ebinger, Martin
- Schuhmann, Martin U.
- Frühwald, Michael C.
- Dürken, Matthias
- Atkinson, Jeffrey
- Lepage, Pierre
- Zakrzewska, Magdalena
- Liberski, Pawel P.
- Siegel, Peter
- Kulozik, Andreas E.
- Zapatka, Marc
- Guha, Abhijit
- Malkin, David
- Felsberg, Jörg
- Reifenberger, Guido
- Ichimura, Koichi
- Collins, V. Peter
- Witt, Hendrik
- Milde, Till
- Witt, Olaf
- Zhang, Cindy
- Lichter, Peter
- Faury, Damien
- Tabori, Uri
- Plass, Christoph
- Majewski, Jacek
- Pfister, Stefan M.
- Jabado, Nada
- Venue
- Nature
- Published
- 2012-01-29
- Volume
- 482
- Issue
- 7384
- Pages
- 226-231
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2158233796
- Cited by
- 2,631
- References
- 35
- Citations by year
- 2026: 109 · 2025: 138 · 2024: 188 · 2023: 189 · 2022: 200 · 2021: 226 · 2020: 238 · 2019: 188 · 2018: 166 · 2017: 200 · 2016: 174 · 2015: 165 · 2014: 189 · 2013: 166 · 2012: 90
- FWCI
- 92.99
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-03-28)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- NPARC (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
- Semmelweis University Repository (Semmelweis University) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Funders
- Cancer Research Institute
- Genome Canada
- Brain Tumour Charity (10/106)
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- H3F3A mutation, histone H3.3, ATRX mutation, chromatin remodeling, somatic mutations, TP53 mutation, H3K27M mutation, histone modifications, histone deacetylase inhibitors
- MeSH terms
- X-linked Nuclear Protein, Base Sequence, Child, Chromatin, DNA Mutational Analysis, DNA Helicases, Glioblastoma, Histones, Humans, Molecular Sequence Data, Mutation, Nuclear Proteins, Tumor Suppressor Protein p53, Telomere, Molecular Chaperones, Gene Expression Profiling, Chromatin Assembly and Disassembly, Adaptor Proteins, Signal Transducing, Co-Repressor Proteins, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.